MCR - Dsc-11-2357-44

Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms.

PHASE

III

NCT Number

NCT01761968

DEFINITION

Pharmacological

SPONSOR

Italfarmaco